Highlights Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Market Closed - Nasdaq Stockholm Other stock markets 06:59:52 2024-04-30 am EDT			5-day change	1st Jan Change
379 ^SEK	+0.53%		+20.70%	+15.02%

Apr. 24	Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	DJ
Apr. 24	Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	Apr. 24	DJ
Xvivo Perfusion AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Xvivo Perfusion AB Announces Results from Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague	Apr. 11	CI
Xvivo Perfusion AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 25	CI
Xvivo Perfusion AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 25	CI
Xvivo Perfusion AB Announces Results from A Australian/New Zealand Study Using Xvivo's Heart Technology Published	Nov. 03	CI
Xvivo Perfusion AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Xvivo Perfusion AB Announces Leading Acacemic Medical Center Performs First Heart Transplant in the U.S. Utilizing NIHP Technology as Part of Xvivo's Preserve Clinical Trial	23-10-23	CI
US Food & Drug Administration Grants Xvivo Perfusion AB Approval to Include DCD Heartarts in IDE Clinical Trial	23-07-25	CI
Xvivo Perfusion AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-13	CI
Xvivo Perfusion AB Announces Its Decision to Close the PrimECC(R) Study for Further Patient Inclusions - Strategic Opportunities Will Be Evaluated	23-07-12	CI
XVIVO Perfusion AB Enters into A Strategic Collaboration with MTJ Aviation to Strengthen Organ Procurement Services in the US	23-07-10	CI
Xvivo Announces Patient Inclusion Completed in European Clinical Trial with Heart Preservation Technology	23-05-23	CI
Patient Inclusion Completed in European Clinical Trial with XVIVO's Heart Preservation Technology	23-05-23	CI
Xvivo Perfusion AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Xvivo Perfusion AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-26	CI
Xvivo Perfusion AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-26	CI
XVIVO Perfusion Purchases Machine and Perfusion Unit from Avionord in Carve-Out	22-11-30	MT
Xvivo Perfusion AB (OM:XVIVO) completed the acquisition of Machine and perfusion business of Avionord Srl from Avionord S.r.l. for Ã‡12 million.	22-11-29	CI
Xvivo Perfusion AB Presents Positive Results from the Australian & New Zealand Heart Preservation Study	22-11-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Highlights

Filters